Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 12/20 | 0.55 |
| ▸ | NTSR2 | O95665 | 11/20 | 0.55 |
| ▸ | SORT1 | Q99523 | 9/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31233948 | 1.00 | SLC6A2 (0.61) | SLC6A2CALCRLNTSR1NTSR2SORT1 | |
| SCHEMBL31233911 | 0.95 | SLC6A2 (0.63) | SLC6A2CALCRLNTSR1NTSR2SORT1 | |
| SCHEMBL31233798 | 0.95 | SLC6A2 (0.63) | SLC6A2CALCRLNTSR1NTSR2SORT1 | |
| SCHEMBL29465928 | 0.94 | NTSR1 (0.60) | SLC6A2NTSR1NTSR2SORT1 | |
| SCHEMBL29796754 | 0.94 | NTSR1 (0.60) | SLC6A2NTSR1NTSR2SORT1 | |
| SCHEMBL31086923 | 0.94 | NTSR1 (0.60) | SLC6A2NTSR1NTSR2SORT1 | |
| SCHEMBL31233755 | 0.93 | SLC6A2 (0.64) | SLC6A2CALCRLNTSR1NTSR2SORT1 | |
| SCHEMBL30092566 | 0.92 | NTSR1 (0.59) | SLC6A2NTSR1NTSR2SORT1F2 | |
| SCHEMBL29796613 | 0.89 | NTSR1 (0.60) | SLC6A2NTSR1NTSR2SORT1 | |
| SCHEMBL29796500 | 0.89 | NTSR1 (0.60) | SLC6A2NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12171734-B2 | Pathogenic bacteria | SPOREGEN LIMITED (GB) | 2024-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171734-B2 | Pathogenic bacteria | CLPP, CLPX, ANTXR2 | SLC6A2 3807/4885CALCRL 3111/4885NTSR1 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.